Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID Reference, 4th edition, 372 pages

+ the daily Top 10


  Alzheimer's Disease

  Free Subscription


Articles published in Neuroscience

Retrieve available abstracts of 66 articles:
HTML format



Single Articles


    June 2020
  1. ZHU Z, Zhang L, Cui Y, Li M, et al
    Functional compensation and mechanism of choline acetyltransferase in the treatment of cognitive deficits in aged dementia mice.
    Neuroscience. 2020 Jun 1. pii: S0306-4522(20)30313.
    PubMed     Abstract available


    May 2020
  2. ROSAS-HERNANDEZ H, Cuevas E, Raymick JB, Robinson BL, et al
    Impaired amyloid beta clearance and brain microvascular dysfunction are present in the Tg-SwDI mouse model of Alzheimer's disease.
    Neuroscience. 2020 May 22. pii: S0306-4522(20)30321.
    PubMed     Abstract available


    April 2020
  3. CHIDAMBARAM H, Chinnathambi S
    G-Protein coupled receptors and tau-different roles in alzheimer's disease.
    Neuroscience. 2020 Apr 23. pii: S0306-4522(20)30241.
    PubMed     Abstract available


    March 2020
  4. MALLOZZI C, Crestini A, D'Amore C, Piscopo P, et al
    Activation of tyrosine phosphorylation signaling in erythrocytes of patients with alzheimer's disease.
    Neuroscience. 2020 Mar 7. pii: S0306-4522(20)30143.
    PubMed     Abstract available


  5. LI F, Xie XY, Sui XF, Wang P, et al
    Profile of pathogenic proteins and microRNAs in plasma-derived extracellular vesicles in Alzheimer's disease: A pilot study.
    Neuroscience. 2020 Mar 2. pii: S0306-4522(20)30137.
    PubMed     Abstract available


    February 2020
  6. ALVES VS, Arcisio-Miranda M, Carrettiero DC, Oliveira FA, et al
    Transport of glucose by the plasma membrane affects the removal and concentration of Ca(2+) at rest in neurons - Implications of a condition prior to Alzheimer's disease?
    Neuroscience. 2020 Feb 11. pii: S0306-4522(20)30078.
    PubMed     Abstract available


    January 2020
  7. MA X, Zhuo Z, Wei L, Ma Z, et al
    Erratum to 'Altered Temporal Organization of Brief Spontaneous Brain Activities in Patients with Alzheimer's Disease' [Neuroscience 425C (2020) 1-11].
    Neuroscience. 2020 Jan 11. pii: S0306-4522(20)30001.
    PubMed    


  8. WHYTE LS, Hassiotis S, Hattersley KJ, Hemsley KM, et al
    Lysosomal dysregulation in the murine App(NL-G-F/NL-G-F) model of Alzheimer's disease.
    Neuroscience. 2020 Jan 6. pii: S0306-4522(19)30897.
    PubMed     Abstract available


    November 2019
  9. MA X, Zhuo Z, Wei L, Ma Z, et al
    Altered Temporal Organization of Brief Spontaneous Brain Activities in Patients with Alzheimer's Disease.
    Neuroscience. 2019 Nov 27. pii: S0306-4522(19)30801.
    PubMed     Abstract available


  10. VON RUDEN EL, Zellinger C, Gedon J, Walker A, et al
    Regulation of Alzheimer's disease-associated proteins during the course of epileptogenesis: differential proteomic analysis in a rat model.
    Neuroscience. 2019 Nov 6. pii: S0306-4522(19)30612.
    PubMed     Abstract available


  11. BAMFORD RA, Widagdo J, Takamura N, Eve M, et al
    The Interaction Between Contactin and Amyloid Precursor Protein and Its Role in Alzheimer's Disease.
    Neuroscience. 2019 Nov 6. pii: S0306-4522(19)30692.
    PubMed     Abstract available


  12. CHATTERJEE M, Teunissen C
    Contactins & Alzheimer's disease Synaptic proteins, contactins may contribute to the pathology of Alzheimer's disease.
    Neuroscience. 2019 Nov 1. pii: S0306-4522(19)30741.
    PubMed    


  13. VOSOUGHI A, Sadigh-Eteghad S, Ghorbani M, Shahmorad S, et al
    Mathematical Models to Shed Light on Amyloid-Beta and Tau Protein Dependent Pathologies in Alzheimer's Disease.
    Neuroscience. 2019 Nov 1. pii: S0306-4522(19)30662.
    PubMed     Abstract available


    October 2019
  14. FRAGA VG, Magalhaes CA, de Mello Gomide Loures C, de Souza LC, et al
    Inflammatory and Pro-resolving Mediators in Frontotemporal Dementia and Alzheimer's Disease.
    Neuroscience. 2019 Oct 22. pii: S0306-4522(19)30653.
    PubMed     Abstract available


    August 2019
  15. XIA E, Xu F, Hu C, Kumal JPP, et al
    Young Blood Rescues the Cognition of Alzheimer's Model Mice by Restoring the Hippocampal Cholinergic Circuit.
    Neuroscience. 2019 Aug 9. pii: S0306-4522(19)30552.
    PubMed     Abstract available


  16. SHI X, Ohta Y, Liu X, Shang J, et al
    Coagulation and Complement Change in Alzheimer's Disease with Hypoperfusion.
    Neuroscience. 2019 Aug 5. pii: S0306-4522(19)30541.
    PubMed     Abstract available


  17. AFREEN S, Ferreira A
    Altered Cytoskeletal Composition and Delayed Neurite Elongation in tau45-230-Expressing Hippocampal Neurons.
    Neuroscience. 2019;412:1-15.
    PubMed     Abstract available


    July 2019
  18. LESUIS SL, Lucassen PJ, Krugers HJ
    Early life stress amplifies fear responses and hippocampal synaptic potentiation in the APPswe/PS1dE9 Alzheimer mouse model.
    Neuroscience. 2019 Jul 11. pii: S0306-4522(19)30484.
    PubMed     Abstract available


  19. MANDAI T, Kasahara M, Kurimoto E, Tanaka M, et al
    In Vivo Pharmacological Comparison of TAK-071, a Positive Allosteric Modulator of Muscarinic M1 Receptor, and Xanomeline, an Agonist of Muscarinic M1/M4 Receptor, in Rodents.
    Neuroscience. 2019 Jul 9. pii: S0306-4522(19)30473.
    PubMed     Abstract available


    June 2019
  20. STUART KE, King AE, King NE, Collins JM, et al
    Late-life environmental enrichment preserves short-term memory and may attenuate microglia in male APP/PS1 mice.
    Neuroscience. 2019;408:282-292.
    PubMed     Abstract available


    May 2019
  21. ZHANG F, Tian S, Chen S, Ma Y, et al
    Voxel-Based Morphometry: Improving the Diagnosis of Alzheimer's disease based on an Extreme Learning Machine method from the ADNI cohort.
    Neuroscience. 2019 May 15. pii: S0306-4522(19)30330.
    PubMed     Abstract available


  22. CHERNYUK D, Zernov N, Kabirova M, Bezprozvanny I, et al
    Antagonist of Neuronal Store-Operated Calcium Entry Exerts Beneficial Effects in Neurons Expressing PSEN1DeltaE9 Mutant Linked to Familial Alzheimer Disease.
    Neuroscience. 2019 May 2. pii: S0306-4522(19)30292.
    PubMed     Abstract available


  23. PAOLICELLI RC, Bergamini G, Rajendran L
    Cell-to-cell Communication by Extracellular Vesicles: Focus on Microglia.
    Neuroscience. 2019;405:148-157.
    PubMed     Abstract available


    April 2019
  24. YUAN Q, Zhang H, Zhang X, Huang P, et al
    Association between Axonopathy and Amyloid Plaques in the Spinal Cord of the Transgenic Mice of Alzheimer's Disease.
    Neuroscience. 2019 Apr 26. pii: S0306-4522(19)30286.
    PubMed     Abstract available


    March 2019
  25. SANFILIPPO C, Castrogiovanni P, Imbesi R, Tibullo D, et al
    Middle-aged healthy women and Alzheimer's disease patients present an overlapping of brain cell transcriptional profile.
    Neuroscience. 2019 Mar 11. pii: S0306-4522(19)30159.
    PubMed     Abstract available


    February 2019
  26. PU Z, Ma S, Wang L, Li M, et al
    Corrigendum to "Amyloid-beta Degradation and Neuroprotection of Dauricine Mediated by Unfolded Protein Response in a Caenorhabditis elegans Model of Alzheimer's Disease" [Neuroscience 392C (2018) 25-37].
    Neuroscience. 2019 Feb 24. pii: S0306-4522(19)30075.
    PubMed    


  27. COELHO BP, Gaelzer MM, Dos Santos Petry F, Hoppe JB, et al
    Dual Effect of Doxazosin: Anticancer Activity on SH-SY5Y Neuroblastoma Cells and Neuroprotection on an In Vitro Model of Alzheimer's Disease.
    Neuroscience. 2019 Feb 13. pii: S0306-4522(19)30105.
    PubMed     Abstract available


    January 2019
  28. SEPULVEDA C, Hernandez B, Burgos CF, Fuentes E, et al
    The cAMP/PKA Pathway Inhibits Beta-amyloid Peptide Release from Human Platelets.
    Neuroscience. 2019;397:159-171.
    PubMed     Abstract available


    December 2018
  29. MONDRAGON-RODRIGUEZ S, Gu N, Fasano C, Pena-Ortega F, et al
    dFunctional connectivity between Hippocampus and Lateral septum is affected in very young Alzheimer's transgenic mouse model.
    Neuroscience. 2018 Dec 29. pii: S0306-4522(18)30868.
    PubMed     Abstract available


  30. MACHEDA T, Roberts K, Lyons DN, Higgins E, et al
    Chronic Intermittent Hypoxia Induces Robust Astrogliosis in an Alzheimer's Disease-Relevant Mouse Model.
    Neuroscience. 2018 Dec 7. pii: S0306-4522(18)30782.
    PubMed     Abstract available


  31. OHRFELT A, Brinkmalm A, Dumurgier J, Zetterberg H, et al
    A Novel ELISA for the Measurement of Cerebrospinal Fluid SNAP-25 in Patients with Alzheimer's Disease.
    Neuroscience. 2018 Dec 5. pii: S0306-4522(18)30780.
    PubMed     Abstract available


    November 2018
  32. PAN X, Green BD
    Temporal effects of neuron-specific beta-secretase 1 (BACE1) knock-in on the mouse brain metabolome: implications for Alzheimer's disease.
    Neuroscience. 2018 Nov 26. pii: S0306-4522(18)30764.
    PubMed     Abstract available


  33. WANG S, Huang L, Zhang Y, Peng Y, et al
    Protective Effects of L-3-n-Butylphthalide Against H2O2-Induced Injury in Neural Stem Cells by Activation of PI3K/Akt and Mash1 Pathway.
    Neuroscience. 2018;393:164-174.
    PubMed     Abstract available


  34. BUCCARELLO L, Musi CA, Turati A, Borsello T, et al
    The Stress c-Jun N-terminal Kinase Signaling Pathway Activation Correlates with Synaptic Pathology and Presents A Sex Bias in P301L Mouse Model of Tauopathy.
    Neuroscience. 2018;393:196-205.
    PubMed     Abstract available


    October 2018
  35. LIU Y, Wei M, Yue K, Hu M, et al
    Study on urine metabolic profile of Abeta25-35-induced Alzheimer's disease by using UHPLC-Q-TOF-MS.
    Neuroscience. 2018 Oct 11. pii: S0306-4522(18)30662.
    PubMed     Abstract available


    September 2018
  36. PU Z, Ma S, Wang L, Li M, et al
    Amyloid-beta Degradation and Neuroprotection of Dauricine Mediated by Unfolded Protein Response in a Caenorhabditis elegans model of Alzheimer's disease.
    Neuroscience. 2018 Sep 26. pii: S0306-4522(18)30620.
    PubMed     Abstract available


  37. LIU JY, Chen XX, Chen HY, Shi J, et al
    Downregulation of aquaporin 9 exacerbates beta-amyloid-induced neurotoxicity in Alzheimer's disease models in vitro and in vivo.
    Neuroscience. 2018 Sep 25. pii: S0306-4522(18)30614.
    PubMed     Abstract available


  38. HOOSHMANDI E, Motamedi F, Moosavi M, Katinger H, et al
    CEPO-Fc (An EPO Derivative) Protects Hippocampus Against Abeta-induced Memory Deterioration: A Behavioral and Molecular Study in a Rat Model of Abeta Toxicity.
    Neuroscience. 2018;388:405-417.
    PubMed     Abstract available


    August 2018
  39. AHN KC, Learman CR, Dunbar GL, Maiti P, et al
    Characterization of Impaired Cerebrovascular Structure in APP/PS1 Mouse Brains.
    Neuroscience. 2018;385:246-254.
    PubMed     Abstract available


    June 2018
  40. GROLEAU M, Chamoun M, Vaucher E
    Stimulation of acetylcholine release and pharmacological potentiation of cholinergic transmission affect cholinergic receptor expression differently during visual conditioning.
    Neuroscience. 2018 Jun 26. pii: S0306-4522(18)30434.
    PubMed     Abstract available


  41. PU D, Zhao Y, Chen J, Sun Y, et al
    Protective Effects of Sulforaphane on Cognitive Impairments and AD-like Lesions in Diabetic Mice are Associated with the Upregulation of Nrf2 Transcription Activity.
    Neuroscience. 2018;381:35-45.
    PubMed     Abstract available


  42. HUANG J, Chen S, Hu L, Niu H, et al
    Mitoferrin-1 is Involved in the Progression of Alzheimer's Disease Through Targeting Mitochondrial Iron Metabolism in a Caenorhabditis elegans Model of Alzheimer's Disease.
    Neuroscience. 2018 Jun 13. pii: S0306-4522(18)30422.
    PubMed     Abstract available


    May 2018
  43. LI J, Rao D, Gibbs RB
    Effects of Cholinergic Lesions and Cholinesterase Inhibitors on Aromatase and Estrogen Receptor Expression in Different Regions of the Rat Brain.
    Neuroscience. 2018 May 28. pii: S0306-4522(18)30383.
    PubMed     Abstract available


  44. ELFAKHRI KH, Duong QV, Langley C, Depaula A, et al
    Characterization of Hit Compounds Identified from High-throughput Screening for their Effect on Blood-brain Barrier Integrity and Amyloid-beta Clearance: In Vitro and In Vivo Studies.
    Neuroscience. 2018;379:269-280.
    PubMed     Abstract available


  45. CHOI S, Won JS, Carroll SL, Annamalai B, et al
    Pathology of nNOS expressing GABAergic neurons in mouse model of Alzheimer's disease.
    Neuroscience. 2018 May 18. pii: S0306-4522(18)30356.
    PubMed     Abstract available


    March 2018
  46. AGUADO-LLERA D, Canelles S, Frago LM, Chowen JA, et al
    The Protective Effects of IGF-I against beta-Amyloid-related Downregulation of Hippocampal Somatostatinergic System Involve Activation of Akt and Protein Kinase A.
    Neuroscience. 2018;374:104-118.
    PubMed     Abstract available


  47. IZUMI H, Shinoda Y, Saito T, Saido T, et al
    The disease-modifying drug candidate, SAK3 improves cognitive impairment and inhibits amyloid beta deposition in App knock-in mice.
    Neuroscience. 2018 Mar 3. pii: S0306-4522(18)30156.
    PubMed     Abstract available


    February 2018
  48. MURRAY HC, Swanson MEV, Dieriks BV, Turner C, et al
    Neurochemical Characterization of PSA-NCAM(+) Cells in the Human Brain and Phenotypic Quantification in Alzheimer's Disease Entorhinal Cortex.
    Neuroscience. 2018;372:289-303.
    PubMed     Abstract available


  49. DE LIMA OLIVEIRA BC, Bellozi PMQ, Reis HJ, de Oliveira ACP, et al
    Inflammation as a possible link between dyslipidemia and Alzheimer's disease.
    Neuroscience. 2018 Feb 14. pii: S0306-4522(18)30127.
    PubMed     Abstract available


  50. NOVELLINO F, Vasta R, Sarica A, Chiriaco C, et al
    Relationship between Hippocampal Subfields and Category Cued Recall in AD and PDD: A Multimodal MRI Study.
    Neuroscience. 2018;371:506-517.
    PubMed     Abstract available


  51. SIMON E, Obst J, Gomez-Nicola D
    The evolving dialogue of microglia and neurons in Alzheimer's disease: microglia as necessary transducers of pathology.
    Neuroscience. 2018 Feb 7. pii: S0306-4522(18)30089.
    PubMed     Abstract available


    January 2018
  52. NACHER J
    Plasticity Molecule Reveals Interneuronal Alterations in Alzheimer's Disease.
    Neuroscience. 2018 Jan 17. pii: S0306-4522(18)30028.
    PubMed    


  53. OMTRI RS, Thompson K, Tang X, Gali CC, et al
    Differential Effects of Alzheimer's Disease Abeta40 and 42 on Endocytosis and Intraneuronal Trafficking.
    Neuroscience. 2018 Jan 11. pii: S0306-4522(18)30019.
    PubMed     Abstract available


  54. NYARKO JNK, Quartey MO, Pennington PR, Heistad RM, et al
    Profiles of beta-amyloid peptides and key secretases in brain autopsy samples differ with sex and APOE epsilon4 status: impact for risk and progression of Alzheimer disease.
    Neuroscience. 2018 Jan 10. pii: S0306-4522(18)30021.
    PubMed     Abstract available


    November 2017
  55. MASCALI D, DiNuzzo M, Serra L, Mangia S, et al
    Disruption of Semantic Network in Mild Alzheimer's Disease Revealed by Resting-State fMRI.
    Neuroscience. 2017 Nov 29. pii: S0306-4522(17)30824.
    PubMed     Abstract available


    October 2017
  56. LI J, Gong Y, Tang X
    Hierarchical subcortical sub-regional shape network analysis in Alzheimer's disease.
    Neuroscience. 2017 Oct 13. pii: S0306-4522(17)30730.
    PubMed     Abstract available


    August 2017
  57. DJORDJEVIC J, Thomson E, Chowdhury SR, Snow WM, et al
    Brain region- and sex-specific alterations in mitochondrial function and NF-kappaB signaling in the TgCRND8 mouse model of Alzheimer's disease.
    Neuroscience. 2017 Aug 9. pii: S0306-4522(17)30564.
    PubMed     Abstract available


    July 2017
  58. EL KADMIRI N, Said N, Slassi I, El Moutawakil B, et al
    Biomarkers for Alzheimer disease: Classical and novel candidates' review.
    Neuroscience. 2017 Jul 17. pii: S0306-4522(17)30487.
    PubMed     Abstract available


    June 2017
  59. KORABECNY J, Nepovimova E, Cikankova T, Spilovska K, et al
    Newly developed drugs for Alzheimer's disease in relation to energy metabolism, cholinergic and monoaminergic neurotransmission.
    Neuroscience. 2017 Jun 30. pii: S0306-4522(17)30439.
    PubMed     Abstract available


    May 2017
  60. QIU WQ
    Amylin and its G-protein-coupled receptor: a probable pathological process and drug target for Alzheimer's disease.
    Neuroscience. 2017 May 18. pii: S0306-4522(17)30349.
    PubMed     Abstract available


    April 2017
  61. OLIVEIRA-SOUZA FG, DeRamus ML, van Groen T, Lambert AE, et al
    Retinal changes in the Tg-SwDI mouse model of Alzheimer's disease.
    Neuroscience. 2017 Apr 25. pii: S0306-4522(17)30270.
    PubMed     Abstract available


  62. ESTEVES IM, Lopes-Aguiar C, Rossignoli MT, Ruggiero RN, et al
    Chronic nicotine attenuates behavioral and synaptic plasticity impairments in a streptozotocin model of Alzheimer's disease.
    Neuroscience. 2017 Apr 19. pii: S0306-4522(17)30258.
    PubMed     Abstract available


  63. FUHRER TE, Palpagama TH, Waldvogel HJ, Synek BJ, et al
    Impaired expression of GABA transporters in the human Alzheimer's disease hippocampus, subiculum, entorhinal cortex and superior temporal gyrus.
    Neuroscience. 2017 Apr 3. pii: S0306-4522(17)30207.
    PubMed     Abstract available


    January 2017
  64. CHEN JL, Zhang DL, Sun Y, Zhao YX, et al
    Angiotensin-(1-7) administration attenuates Alzheimer's disease-like neuropathology in rats with streptozotocin-induced diabetes via Mas receptor activation.
    Neuroscience. 2017 Jan 29. pii: S0306-4522(17)30040.
    PubMed     Abstract available


    March 2016
  65. VECCHIO F, Miraglia F, Quaranta D, Granata G, et al
    Cortical connectivity and memory performance in cognitive decline: A study via graph theory from EEG data.
    Neuroscience. 2016;316:143-50.
    PubMed     Abstract available


    January 2016
  66. SARLAK G, Htoo HH, Hernandez JF, Iizasa H, et al
    Sox2 functionally interacts with betaAPP, the betaAPP intracellular domain and ADAM10 at a transcriptional level in human cells.
    Neuroscience. 2016;312:153-64.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: